Eurofarma Laboratórios S.A. Stock

Stocks

EUFA3

BREUFAACNOR4

Delayed Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news : Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
25-10-21	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
25-10-21	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
25-08-21	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-03-16	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
24-11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	2021-11-22
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	2021-11-22

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	2021-11-22
Cristina Presz Palmaka de Luca BRD	Director/Board Member	57	2021-11-22
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	2018-12-31

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
1/10/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
12/4/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
12/4/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.13B 1.83B 1.71B 1.56B 2.95B 203B 2.97B 20.28B 7.86B 102B 7.99B 7.81B 339B	12.48B 2.42B 2.08B 1.95B 1.78B 3.36B 231B 3.37B 23.06B 8.94B 116B 9.08B 8.88B 385B
Net income	117M 22.73M 19.51M 18.31M 16.73M 31.56M 2.17B 31.72M 217M 83.99M 1.09B 85.35M 83.5M 3.62B	571M 111M 95.06M 89.23M 81.49M 154M 10.56B 155M 1.06B 409M 5.33B 416M 407M 17.65B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company